Alcon (ALC)
(Delayed Data from NYSE)
$94.47 USD
-1.23 (-1.29%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $94.42 -0.05 (-0.05%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth C Momentum D VGM
Alcon (ALC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$102.17 | $116.00 | $85.00 | 6.76% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Alcon comes to $102.17. The forecasts range from a low of $85.00 to a high of $116.00. The average price target represents an increase of 6.76% from the last closing price of $95.70.
Analyst Price Targets (15)
Broker Rating
Alcon currently has an average brokerage recommendation (ABR) of 1.61 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 18 brokerage firms. The current ABR compares to an ABR of 1.61 a month ago based on 18 recommendations.
Of the 18 recommendations deriving the current ABR, 13 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 72.22% and 5.56% of all recommendations. A month ago, Strong Buy made up 72.22%, while Buy represented 5.56%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/ALC.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 13 | 13 | 13 | 13 | 13 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 2 | 2 |
Sell | 0 | 0 | 0 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.61 | 1.61 | 1.61 | 1.65 | 1.65 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/22/2024 | Robert W. Baird & Co. | Jeffrey D Johnson | Strong Buy | Strong Buy |
8/22/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/22/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
8/22/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
8/21/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/21/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/14/2024 | Needham & Company | David Saxon | Moderate Buy | Moderate Buy |
8/1/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/15/2024 | BTIG | Ryan Zimmerman | Strong Buy | Strong Buy |
4/10/2024 | Goldman Sachs | Richard Felton | Not Available | Strong Buy |
3/14/2024 | Not Identified | Not Identified | Not Available | Hold |
3/4/2024 | Argus Research Corp. | John D Staszak | Strong Buy | Strong Buy |
2/29/2024 | KeyBanc Capital Markets | Brett Fishbin | Strong Buy | Strong Buy |
2/28/2024 | UBS | Graham Doyle | Strong Buy | Strong Buy |
12/18/2023 | Atlantic Equities | Issie Kirby | Not Available | Strong Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.61 |
ABR (Last week) | 1.61 |
# of Recs in ABR | 18 |
Average Target Price | $102.17 |
LT Growth Rate | 14.60% |
Industry | Medical - Instruments |
Industry Rank by ABR | 77 of 253 |
Current Quarter EPS Est: | 0.73 |